AGEN – agenus inc. (US:NASDAQ)
Stock Stats
News
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer [Yahoo! Finance]
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer
Agenus (AGEN) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
Agenus (AGEN) was upgraded by Zacks Research from "hold" to "strong-buy".
Agenus (AGEN) was upgraded by Wall Street Zen from "hold" to "buy".
Form 4 AGENUS INC For: Apr 01 Filed by: HARRISON THOMAS L
Form 4 AGENUS INC For: Apr 03 Filed by: ARMEN GARO H
Form 4 AGENUS INC For: Apr 01 Filed by: Wright Timothy
Form SCHEDULE 13G/A AGENUS INC Filed by: VANGUARD GROUP INC
Form 8-K AGENUS INC For: Mar 24
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.